Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Tanner

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Advances in Neurology|January 1, 1983
Serotonergically active agents in levodopa-induced psychiatric toxicity reactionsP A Nausieda, C M Tanner, H L Klawans
Advances in Neurology|January 1, 1984
The pharmacology of olivopontocerebellar atrophyC G Goetz, C M Tanner, H L Klawans
Advances in Neurology|January 1, 1982
Compressive neuropathies in Tourette syndromeC G Goetz, C M Tanner, H L Klawans
Neurology|August 1, 1984
Bupropion in Parkinson's diseaseC G Goetz, C M Tanner, H L Klawans
Annals of Neurology|November 1, 1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinationsC L Comella, C M Tanner, R K Ristanovic
The American Journal of Psychiatry|April 1, 1982
Pharmacology of hallucinations induced by long-term drug therapyC G Goetz, C M Tanner, H L Klawans
Neurology|November 1, 1982
Cholinergic mechanisms in Tourette syndromeC M Tanner, C G Goetz, H L Klawans
Neurology|November 1, 1981
Weekly drug holiday in Parkinson diseaseC G Goetz, C M Tanner, P A Nausieda
Archives of Neurology|December 1, 1981
Opsoclonic cerebellopathy: A paraneoplastic syndrome responsive to thiamineP A Nausieda, C M Tanner, W J Weiner
Neurology|March 4, 1998
Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's diseaseP Chan, C M Tanner, X Jiang, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Advances in Neurology|January 1, 1983
Serotonergically active agents in levodopa-induced psychiatric toxicity reactionsP A Nausieda, C M Tanner, H L Klawans
Advances in Neurology|January 1, 1984
The pharmacology of olivopontocerebellar atrophyC G Goetz, C M Tanner, H L Klawans
Advances in Neurology|January 1, 1982
Compressive neuropathies in Tourette syndromeC G Goetz, C M Tanner, H L Klawans
Neurology|August 1, 1984
Bupropion in Parkinson's diseaseC G Goetz, C M Tanner, H L Klawans
Annals of Neurology|November 1, 1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinationsC L Comella, C M Tanner, R K Ristanovic
The American Journal of Psychiatry|April 1, 1982
Pharmacology of hallucinations induced by long-term drug therapyC G Goetz, C M Tanner, H L Klawans
Neurology|November 1, 1982
Cholinergic mechanisms in Tourette syndromeC M Tanner, C G Goetz, H L Klawans
Neurology|November 1, 1981
Weekly drug holiday in Parkinson diseaseC G Goetz, C M Tanner, P A Nausieda
Archives of Neurology|December 1, 1981
Opsoclonic cerebellopathy: A paraneoplastic syndrome responsive to thiamineP A Nausieda, C M Tanner, W J Weiner
Neurology|March 4, 1998
Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's diseaseP Chan, C M Tanner, X Jiang, et al.
Pageof 14